Background: Neoadjuvant chemoradiotherapy (nCRT) or chemotherapy (nCT) is standard of care for resectable oesophageal cancer and improves margin negative resection rates and overall survival (OS). The aim of this study was to examine survival outcomes of patients with oesophageal cancer who received neoadjuvant therapy and to examine the prognostic significance of post-neoadjuvant stage based on the neoadjuvant therapy received.
No takes yet. Share an insight, caveat, or question.
Gunadasa et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: